Modern to offer its Kovid-19 vaccine to workers, contractors and board

Moderna Inc.

mRNA 2.68%

On Tuesday, it said it would offer this new Kovid-19 vaccine to its employees, contractors and board members, which the company said would provide an additional layer of protection to workers involved in making and delivering the vaccine.

The Cambridge, Mass., Company, which has about 1,200 employees, said the small amount of vaccines needed for the program is different from the millions of doses that modernism has given to the U.S. government.

Modern has said it expects to provide around 20 million doses for use in the US by the end of this month, and a total of about 200 million by mid-2021. The federal government has purchased the supplements and is overseeing their distribution.

Vaccination using Modern’s Kovid-19 vaccine began earlier this month. Betsy McKay of the WSJ reports on how the injections are being delivered. Photo: Paul Sankya / Agence France-Press / Getty Image

The company’s new policy will appear to allow vaccination of some people who are not in the high-priority groups identified by the Centers for Disease Control and Prevention. The CDC has stated that the first people who should receive a limited initial supply of available vaccine supplements are health care workers and residents of long-term care facilities, followed by people 75 years and older and some essential workers such as police officers and manufacturing personnel.

A modern spokesperson said the policy would help assure “ongoing operations and vaccine production in the event of an epidemic”.

The US Food and Drug Administration this month authorized the emergency use of Modern’s vaccine in adults after a large study revealed it was highly effective against Kovid-19 disease. Till now millions of doses have been distributed to sites around the US. Dr. Federal health officials, including Anthony Fauci, received the first dose of the modern vaccine.

The company said that under its new policy it would also vaccinate adult members of its workers’ homes to reduce the risk of absenteeism and disruption due to a family member’s Kovid-19 infection. The company is making vaccination voluntary and confidential and is covering costs.

Modern said it informed the appropriate health authorities about the program and that it would monitor and report on vaccinations as required under FDA authorization.

Modern officials have previously stated that they have taken steps to reduce the risk of the virus for workers, including the need for personal protective equipment for those who work in its facilities, and some employees who work from home .

Write Peter Loftus at [email protected]

Copyright © 2020 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8


Leave a Reply

Your email address will not be published.